XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue $ 200,499 $ 417,905
Cost of revenue 122,918 275,268
Gross Profit 77,581 142,637
Operating Expenses    
Research and development 721,347 122,983
Selling, general, and administrative 3,534,923 1,492,811
Total Operating Expenses 4,256,270 1,615,794
Loss From Operations (4,178,689) (1,473,157)
Other Income (Expense)    
Interest expense, net (906) (865)
Amortization of debt discount 0 (108,124)
Change in fair value of accrued issuable equity 43,040 (132,577)
Total Other Income (Expense), net 42,134 (241,566)
Net Loss $ (4,136,555) $ (1,714,723)
Net Loss Per Share - Basic (In dollars per share) $ (0.04) $ (0.02)
Net Loss Per Share - Diluted (In dollars per share) $ (0.04) $ (0.02)
Weighted Average Number of Common Shares Outstanding - Basic (In Shares) 102,561,211 90,078,940
Weighted Average Number of Common Shares Outstanding - Diluted (In Shares) 102,561,211 90,078,940